BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 14695529)

  • 1. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
    Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
    Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel A121T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site.
    Felderbauer P; Schnekenburger J; Lebert R; Bulut K; Parry M; Meister T; Schick V; Schmitz F; Domschke W; Schmidt WE
    J Med Genet; 2008 Aug; 45(8):507-12. PubMed ID: 18511571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of trypsinogen gene mutations in the etiology of hereditary pancreatitis].
    Sahin-Tóth M; Tóth M
    Orv Hetil; 2001 Mar; 142(12):603-6. PubMed ID: 11324217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.
    Bernardino AL; Guarita DR; Mott CB; Pedroso MR; Machado MC; Laudanna AA; Tani CM; Almeida FL; Zatz M
    JOP; 2003 Sep; 4(5):169-77. PubMed ID: 14526128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.
    Räty S; Piironen A; Babu M; Pelli H; Sand J; Uotila S; Nordback I; Herzig KH
    Scand J Gastroenterol; 2007 Aug; 42(8):1000-5. PubMed ID: 17613931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathobiochemistry of hereditary pancreatitis: studies on recombinant human cationic trypsinogen.
    Sahin-Tóth M
    Pancreatology; 2001; 1(5):461-5. PubMed ID: 12120225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.
    Teich N; Bauer N; Mössner J; Keim V
    Am J Gastroenterol; 2002 Feb; 97(2):341-6. PubMed ID: 11866271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course of genetically determined chronic pancreatitis.
    Keim V; Witt H; Bauer N; Bodeker H; Rosendahl J; Teich N; Mossner J
    JOP; 2003 Jul; 4(4):146-54. PubMed ID: 12853682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology and evolutionary and physiological implications of pancreatitis-associated cationic trypsinogen mutations.
    Chen JM; Montier T; Férec C
    Hum Genet; 2001 Sep; 109(3):245-52. PubMed ID: 11702203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary chronic pancreatitis.
    Teich N; Mössner J
    Best Pract Res Clin Gastroenterol; 2008; 22(1):115-30. PubMed ID: 18206817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen.
    Sahin-Tóth M; Tóth M
    Biochem Biophys Res Commun; 2000 Nov; 278(2):286-9. PubMed ID: 11097832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.
    Jancsó Z; Sahin-Tóth M
    J Biol Chem; 2016 Jun; 291(25):12897-905. PubMed ID: 27129265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic trypsinogen mutations and pancreatitis.
    Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
    Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel pancreatitis-associated missense mutation, R116C, in the human cationic trypsinogen gene (PRSS1).
    Le Maréchal C; Bretagne JF; Raguénès O; Quéré I; Chen JM; Ferec C
    Mol Genet Metab; 2001 Nov; 74(3):342-4. PubMed ID: 11708864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families.
    Grocock CJ; Rebours V; Delhaye MN; Andrén-Sandberg A; Weiss FU; Mountford R; Harcus MJ; Niemczyck E; Vitone LJ; Dodd S; Jørgensen MT; Ammann RW; Schaffalitzky de Muckadell O; Butler JV; Burgess P; Kerr B; Charnley R; Sutton R; Raraty MG; Devière J; Whitcomb DC; Neoptolemos JP; Lévy P; Lerch MM; Greenhalf W;
    Gut; 2010 Mar; 59(3):357-63. PubMed ID: 19951905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypsinogen stabilization by mutation Arg117-->His: a unifying pathomechanism for hereditary pancreatitis?
    Sahin-Tóth M; Gráf L; Tóth M
    Biochem Biophys Res Commun; 1999 Oct; 264(2):505-8. PubMed ID: 10529393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic trypsinogen mutations and pancreatitis.
    Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
    Clin Lab Med; 2005 Mar; 25(1):39-59. PubMed ID: 15749231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications.
    Truninger K; Ammann RW; Blum HE; Witt H
    Swiss Med Wkly; 2001 Oct; 131(39-40):565-74. PubMed ID: 11775491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copy number variations in chronic pancreatitis.
    Chen JM; Masson E; Le Maréchal C; Férec C
    Cytogenet Genome Res; 2008; 123(1-4):102-7. PubMed ID: 19287144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
    Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE
    Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.